Older adults develop protection on the same timeline (3 weeks), but the rate is 87% versus 98% for younger adults. This is still excellent protection. Unlike the previous IXCHIQ vaccine which had safety concerns for people over 60, Vimkunya® has no safety signals in older adults and is recommended for all ages 12+.